Oppenheimer Expands Its Global Investment Banking Capabilities with the Addition of Martin Chamberlin

Rhea-AI Summary

Oppenheimer Holdings, a leading investment bank and wealth manager, has expanded its European investment banking division by appointing Martin Chamberlin as Managing Director and Head of European Healthcare. Chamberlin, based in London, brings over 20 years of experience in healthcare investment banking and will lead the firm's new healthcare M&A practice. His previous role was with RBC Capital Markets, focusing on European Healthcare Investment Banking. This strategic move aims to bolster Oppenheimer's global advisory and capital markets presence, aligning with its successful North American healthcare investment banking operations.

Positive

• Martin Chamberlin's appointment enhances Oppenheimer's healthcare M&A practice in Europe.
• Chamberlin brings over 20 years of experience in healthcare investment banking.
• Strengthened presence in the strategically important healthcare sector.
• Opportunity to leverage Martin's extensive track record with corporate, private equity, and infrastructure fund clients.
• Alignment with Oppenheimer's successful North American healthcare investment banking business.

Negative

• Potential high costs associated with establishing a new healthcare M&A practice.
• Risk of integration challenges with existing European operations.
• Possible delays in realizing returns from the new practice.

Highly experienced, London-based banker to lead firm's newly established Healthcare M&A practice

NEW YORK, June 4, 2024 /PRNewswire/ -- Oppenheimer Europe (Oppenheimer) — a subsidiary of Oppenheimer Holdings, the leading investment bank and wealth manager (NYSE: OPY) — announced today a further expansion of its European investment banking footprint with the addition of Martin Chamberlin.

Based in London, Chamberlin will serve as a Managing Director and Head of European Healthcare. In that role, he will lead the firm's newly established European healthcare practice and report to Max Lami, Chief Executive Officer of Oppenheimer Europe.

"Martin's arrival comes at a key time for Oppenheimer, allowing the firm to service our clients in Europe in the strategically important healthcare sector," Lami said. "As we continue to cement Oppenheimer as a leading global advisory and capital markets firm, Martin will build a European-based practice that will complement our highly successful healthcare investment banking business in North America."

Chamberlin joins Oppenheimer with over 20 years of experience. During his career, he has advised a broad range of corporate, private equity and infrastructure fund clients across the healthcare space. Most recently, Chamberlin was a Managing Director with RBC Capital Markets, where he worked on the firm's European Healthcare Investment Banking team.

"I am excited to start working with Martin," said Leigh Webb, Managing Director and Head of Financial Sponsor Coverage for Europe. "As the firm continues to establish itself as a key strategic advisor to M&A-focused private equity funds and fund placement advisory groups in the UK and across Europe, Martin's extensive track record in the healthcare sector will enable us to partner with a wide variety of funds looking to acquire platform businesses and get the most out of their healthcare assets."

Oppenheimer & Co. Inc.
Oppenheimer & Co. Inc. (Oppenheimer), a principal subsidiary of Oppenheimer Holdings Inc. (OPY on the New York Stock Exchange), and its affiliates provide a full range of wealth management, securities brokerage and investment banking services to high net-worth individuals, families, corporate executives, local governments, businesses and institutions.

Oppenheimer Europe Limited
Oppenheimer Europe Limited (Oppenheimer), a subsidiary of Oppenheimer Holdings Inc. (OPY on the New York Stock Exchange) provides financial services to EMEA-based institutions and corporations across corporate finance, equities, fixed income, debt capital markets and portfolio strategy research.

Contact:
Michael Dugan
Haven Tower Group LLC
424 317 4852
mdugan@haventower.com

View original content:https://www.prnewswire.com/news-releases/oppenheimer-expands-its-global-investment-banking-capabilities-with-the-addition-of-martin-chamberlin-302162569.html

SOURCE Oppenheimer & Co. Inc.

FAQ

Who is leading Oppenheimer's newly established European healthcare practice?

Martin Chamberlin is leading Oppenheimer's newly established European healthcare practice.

What experience does Martin Chamberlin bring to Oppenheimer?

Martin Chamberlin brings over 20 years of experience in healthcare investment banking.

How will Martin Chamberlin's appointment impact Oppenheimer's global advisory services?

Martin Chamberlin's appointment aims to strengthen Oppenheimer's global advisory services, particularly in the healthcare sector.

When was Martin Chamberlin appointed to Oppenheimer's European healthcare practice?

Martin Chamberlin was appointed on June 4, 2024.

What was Martin Chamberlin's previous position before joining Oppenheimer?

Martin Chamberlin was a Managing Director with RBC Capital Markets in their European Healthcare Investment Banking team.

What is the stock symbol for Oppenheimer Holdings?

The stock symbol for Oppenheimer Holdings is OPY.